nach oben

International Urogynecology Journal

Erschienen in:

01.07.2011 | Original Article

Validity and reliability of patient selected goals as an outcome measure in overactive bladder

verfasst von: Rufus Cartwright, Sushma Srikrishna, Linda Cardozo, Dudley Robinson

Erschienen in: International Urogynecology Journal | Ausgabe 7/2011

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

The purpose of this study is to assess the validity of patient goal achievement in overactive bladder (OAB).

Methods

Data were taken from a placebo-controlled randomised trial of transdermal oxybutynin and open label extension study. Face validity was assessed using qualitative analysis. Convergent validity was assessed by comparison with objective symptom improvement. Responsiveness was assessed at 4 s, using the standardised effect size. Reliability was assessed between 4 and 12 weeks of treatment.

Results

Ninety-six women were randomised. There were moderate correlations (0.50–0.51) between goal achievement and symptom improvement for urinary urgency and urge incontinence. Mean goal achievement demonstrated good reliability (intraclass correlation = 0.82) but low responsiveness (r = 0.14) between transdermal oxybutynin and placebo-treated groups.

Conclusions

Although patient goals have good face validity and can be reliably measured, they have limited convergence with conventional measures of OAB severity and improvement and low responsiveness.

Khullar V, Chapple C, Gabriel Z, Dooley JA (2006) The effects of antimuscarinics on health-related quality-of-life in overactive bladder: a systematic review and meta-analysis. Urology 68:38–48PubMedCrossRef

Lowenstein L, Fitzgerald MP, Kenton K, Dooley Y, Templehof M, Mueller ER et al (2007) Patient-selected goals: the fourth dimension in assessment of pelvic floor disorders. Int Urogynecol J Pelvic Floor Dysfunct 19:81–84PubMedCrossRef

Brubaker L, Shull B (2005) EGGS for patient-centered outcomes. Int Urogynecol J Pelvic Floor Dysfunct 16:171–173PubMedCrossRef

Hullfish KL, Bovbjerg VE, Gibson J, Steers WD (2002) Patient-centered goals for pelvic floor dysfunction surgery: what is success, and is it achieved? Am J Obstet Gynecol 187:88–92PubMedCrossRef

Elkadry EA, Kenton KS, FitzGerald MP, Shott S, Brubaker L (2003) Patient-selected goals: a new perspective on surgical outcome. Am J Obstet Gynecol 189:1551–1557, discussion 1557–1558PubMedCrossRef

Hullfish KL, Bovbjerg VE, Steers WD (2004) Patient-centered goals for pelvic floor dysfunction surgery: long-term follow-up. Am J Obstet Gynecol 191:201–205PubMedCrossRef

Bovbjerg VE, Trowbridge ER, Barber MD, Martirosian TE, Steers WD, Hullfish KL (2009) Patient-centered treatment goals for pelvic floor disorders: association with quality-of-life and patient satisfaction. Am J Obstet Gynecol 200:568.e1–568.e6CrossRef

Payne C, Allee T (2009) Goal achievement provides new insights into interstitial cystitis/painful bladder syndrome symptoms and outcomes. Neurourol Urodyn 28:13–17PubMedCrossRef

Komesu YM, Rogers RG, Rode MA, Craig EC, Schrader RM, Gallegos KA et al (2008) Patient-selected goal attainment for pessary wearers: what is the clinical relevance? Am J Obstet Gynecol 198:577.e1–577.e5CrossRef

10.

Hullfish KL, Bovbjerg VE, Gurka MJ, Steers WD (2008) Surgical versus nonsurgical treatment of women with pelvic floor dysfunction: patient centered goals at 1 year. J Urol 179:2280–2285, discussion 2285PubMedCrossRef

11.

Brubaker L, Shott S, Tomezsko J, Goldberg RP (2008) Pelvic floor fitness using lay instructors. Obstet Gynecol 111:1298–1304PubMedCrossRef

12.

Choo MS, Doo CK, Lee KS (2007) Satisfaction with tolterodine: assessing symptom-specific patient-reported goal achievement in the treatment of overactive bladder in female patients (STARGATE study). Int J Clin Pract 62:191–196PubMedCrossRef

13.

Brubaker G, Sand D (2009) Botulinum toxin type A (Botox®) demonstrates dose-dependent efficacy and improvements in quality-of-life measures in patients with idiopathic overactive bladder. Int Urogynecol J Pelvic Floor Dysfunct 20:S191–S192

14.

Chapple CR, Artibani W, Cardozo LD, Castro-Diaz D, Craggs M, Haab F et al (2005) The role of urinary urgency and its measurement in the overactive bladder symptom syndrome: current concepts and future prospects. BJU Int 95:335–340PubMedCrossRef

15.

Mahajan ST, Elkadry EA, Kenton KS, Shott S, Brubaker L (2006) Patient-centered surgical outcomes: the impact of goal achievement and urge incontinence on patient satisfaction 1 year after surgery. Am J Obstet Gynecol 194:722–728PubMedCrossRef

16.

Srikrishna R, Cardozo C (2007) Defining surgical cure: do surgical goals meet patient expectations? Neurourol Urodyn 26:596–597

17.

Lee S, Malhotra B, Creanga D, Carlsson M, Glue P (2009) A meta-analysis of the placebo response in antimuscarinic drug trials for overactive bladder. BMC Med Res Methodol 22(9):55CrossRef

18.

Cartwright R, Srikrishna S, Cardozo L, Robinson D (2010) Patient-selected goals in overactive bladder: a placebo controlled randomized double-blind trial of transdermal oxybutynin for the treatment of urgency and urge incontinence. BJU Int 107(1):70–76CrossRef

19.

Cardozo L, Heßdörfer E, Milani R, Arañó P, Dewilde L, Slack M et al (2008) Solifenacin in the treatment of urgency and other symptoms of overactive bladder: results from a randomized, double-blind, placebo-controlled, rising-dose trial. BJU Int 102:1120–1127PubMedCrossRef

20.

Kelleher CJ, Cardozo LD, Khullar V, Salvatore S (1997) A new questionnaire to assess the quality-of-life of urinary incontinent women. Br J Obstet Gynaecol 104:1374–1379PubMedCrossRef

21.

Kelleher CJ, Pleil AM, Reese PR, Burgess SM, Brodish PH (2004) How much is enough and who says so? BJOG 111:605–612PubMedCrossRef

22.

Lowenstein L, Kenton K, Pierce K, Fitzgerald MP, Mueller ER, Brubaker L (2007) Patients’ pelvic goals change after initial urogynecologic consultation. Am J Obstet Gynecol 197:640.e1–640.e3CrossRef

23.

Srikrishna S, Robinson D, Cardozo L, Cartwright R (2008) Experiences and expectations of women with urogenital prolapse: a quantitative and qualitative exploration. BJOG 115:1362–1368PubMedCrossRef

24.

Milne JL, Robert M, Tang S, Drummond N, Ross S (2009) Goal achievement as a patient-generated outcome measure for stress urinary incontinence. Health Expect 12:288–300PubMedCrossRef

25.

Cotterill N, Norton C, Avery KN, Abrams P, Donovan JL (2008) A patient-centered approach to developing a comprehensive symptom and quality-of-life assessment of anal incontinence. Dis Colon Rectum 51:82–87PubMedCrossRef

26.

Hróbjartsson A, Gøtzsche PC (2004) Is the placebo powerless? Update of a systematic review with 52 new randomized trials comparing placebo with no treatment. J Intern Med 256:91–100PubMedCrossRef

27.

Meissner K, Distel H, Mitzdorf U (2007) Evidence for placebo effects on physical but not on biochemical outcome parameters: a review of clinical trials. BMC Med 5:3PubMedCrossRef

28.

von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP et al (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med 147:573–577

Titel: Validity and reliability of patient selected goals as an outcome measure in overactive bladder
verfasst von: Rufus Cartwright
Sushma Srikrishna
Linda Cardozo
Dudley Robinson
Publikationsdatum: 01.07.2011
Verlag: Springer-Verlag
Erschienen in: International Urogynecology Journal / Ausgabe 7/2011
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI: https://doi.org/10.1007/s00192-011-1360-0

Neu im Fachgebiet Gynäkologie und Geburtshilfe

23.04.2024 | Medikamente in Schwangerschaft und Stillzeit | Nachrichten

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Validity and reliability of patient selected goals as an outcome measure in overactive bladder

Abstract

Introduction and hypothesis

Methods

Results

Conclusions

Neu im Fachgebiet Gynäkologie und Geburtshilfe

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Gynäkologie

Springer Medizin

Abstract

Introduction and hypothesis

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2011

Evaluation of urinary incontinence in pregnancy and postpartum in Curitiba Mothers Program: a prospective study

Use of the Gynecare Prolift® system in surgery for pelvic organ prolapse: 1-year outcome

The help-seeking by women with urinary incontinence in Brazil

Contasure-Needleless® compared with transobturator-TVT® for the treatment of stress urinary incontinence

Does concomitant prolapse repair at the time of midurethral sling affect recurrent rates of incontinence?

Changes in vaginal anatomy and sexual function after vaginal surgery

Neu im Fachgebiet Gynäkologie und Geburtshilfe

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Gynäkologie